Midway through trading Tuesday, the Dow traded down 0.49% to 34,698.16 while the NASDAQ fell 0.05% to 15,098.38. The S&P also fell, dropping 0.24% to 4,458.05.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 41,223,890 cases with around 662,260 deaths. India confirmed a total of at least 33,289,570 cases and 443,210 deaths, while Brazil reported over 21,006,420 COVID-19 cases with 587,060 deaths. In total, there were at least 225,389,500 cases of COVID-19 worldwide with more than 4,642,050 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Health care shares gained 0.4% on Tuesday. Meanwhile, top gainers in the sector included BELLUS Health Inc. BLU +undefined% (Get Free Alerts for BLU), up 26% and aTyr Pharma, Inc. LIFE +undefined% (Get Free Alerts for LIFE) up 25%.
In trading on Tuesday, financials shares fell by 1.1%.
Top Headline
The annual inflation rate eased to 5.3% in August compared to a 13-year high level of 5.4% in June. The monthly rate eased to 0.3% versus 0.5% a month ago.
Equities Trading UP
aTyr Pharma, Inc. LIFE +undefined% (Get Free Alerts for LIFE) shares shot up 25% to $11.48 after multiple firms maintained bullish ratings on the stock and raised their respective price targets. aTyr Pharma shares jumped 67% on Monday after the company announced the Phase 1b/2a clinical trial of ATYR1923 in pulmonary sarcoidosis met its primary endpoint.
Shares of FuelCell Energy, Inc. FCEL +undefined% got a boost, shooting 22% to $6.83 after the company reported better-than-expected Q3 results.
BELLUS Health Inc. BLU +undefined% (Get Free Alerts for BLU) shares were also up, gaining 26% to $6.03. The company on Monday announced interim analysis from the Phase 2b SOOTHE trial of BLU-5937 in refractor chronic cough. HC Wainwright on Tuesday raised its price target on the stock.
Equities Trading DOWN
Virpax Pharmaceuticals, Inc. VRPX +36.51% shares tumbled 37% to $6.15 after the company priced a 6.67 million share common stock offering at $6 per share.
Shares of RedHill Biopharma Ltd. RDHL +32.25% were down 32% to $4.99 after the company announced preliminary top-line data from the Phase 2/3 study with opaganib showed that the study did not meet its primary endpoint.
Herbalife Nutrition Ltd. HLF +20.02% was down, falling 16% to $45.65 after the company revised its guidance for the third quarter and full year 2021. The company said it sees Q3 adjusted earnings of $1.00 to $1.20 per share. Herbalife updated its full year adjusted earnings guidance to a range of $4.55 to $4.95 per share, while adjusted EBITDA is being lowered to a range of $860 million to $910 million.
Commodities
In commodity news, oil traded up 0.3% to $70.69, while gold traded up 0.7% to $1,806.90.
Silver traded up 0.2% Tuesday to $23.85 while copper fell 1% to $4.3255.
Euro zone
European shares were mostly lower today. The eurozone’s STOXX 600 declined 0.17%, the Spanish Ibex Index fell 0.66% and the German DAX 30 gained 0.01%. Meanwhile, the London’s FTSE 100 dropped 0.62%, French CAC 40 fell 0.61% and Italy’s FTSE MIB gained 0.08%.
Spanish consumer prices increased 3.3% year-over-year in August following a 2.9% increase in the previous month. The UK unemployment rate dropped to 4.6% in the three months to July.
Economics
The NFIB small business optimism index rose to 100.1 points in August from 99.7 points in the previous month.
The annual inflation rate eased to 5.3% in August compared to a 13-year high level of 5.4% in June. The monthly rate eased to 0.3% versus 0.5% a month ago.
Benzinga does not provide investment advice. All rights reserved.
Recommended Content
Editors’ Picks
AUD/USD jumps above 0.6500 after hot Australian CPI data
AUD/USD extended gains and recaptured 0.6500 in Asian trading, following the release of hotter-than-expected Australian inflation data. The Australian CPI rose 1% in QoQ in Q1 against 0.8% forecast, providing extra legs to the Australian Dollar upside.
USD/JPY hangs near 34-year high at 154.88 as intervention risks loom
USD/JPY is sitting at a multi-decade high of 154.88 reached on Tuesday. Traders refrain from placing fresh bets on the pair as Japan's FX intervention risks loom. Broad US Dollar weakness also caps the upside in the major. US Durable Goods data are next on tap.
Gold price cautious despite weaker US Dollar and falling US yields
Gold retreats modestly after failing to sustain gains despite fall in US Treasury yields, weaker US Dollar. XAU/USD struggles to capitalize following release of weaker-than-expected S&P Global PMIs, fueling speculation about potential Fed rate cuts.
Crypto community reacts as BRICS considers launching stablecoin for international trade settlement
BRICS is intensifying efforts to reduce its reliance on the US dollar after plans for its stablecoin effort surfaced online on Tuesday. Most people expect the stablecoin to be backed by gold, considering BRICS nations have been accumulating large holdings of the commodity.
US versus the Eurozone: Inflation divergence causes monetary desynchronization
Historically there is a very close correlation between changes in US Treasury yields and German Bund yields. This is relevant at the current juncture, considering that the recent hawkish twist in the tone of the Fed might continue to push US long-term interest rates higher and put upward pressure on bond yields in the Eurozone.